Dr. Robert Galamaga, Medical Director of Outpatient Care Centers and a medical oncologist at Cancer Treatment Centers of America® (CTCA) Phoenix, reviewed single-agent and combination targeted therapy advances in renal cell carcinoma in an article published by Targeted Oncology that he authored for Kidney Cancer Awareness Month.